Results 291 to 300 of about 1,006,914 (379)

Behaviour of βmicroglobulin (beta2mic), creatinine and urea clearance over time for continuous veno-venous hemofiltration (CVVH) and continuous veno-venous dialysis (CVVHD)

open access: green, 2011
Ricci Zaccaria   +7 more
openalex   +1 more source

Printed Wearable Sweat Rate Sensor for Continuous In Situ Perspiration Measurement

open access: yesAdvanced Intelligent Systems, Volume 7, Issue 3, March 2025.
A wireless wearable sweat rate sensor system is presented, featuring digital 3D direct‐write printing on a flexible substrate with microfluidic layers for continuous, real‐time monitoring. Printed encapsulated metal electrodes are used for capacitance measurements, achieving high sensitivity (0.01 μL min−1) while maintaining a compact and lightweight ...
Mohammad Shafiqul Islam   +6 more
wiley   +1 more source

Creatinine clearance before and after paracentesis

open access: green, 2011
Andreas Umgelter   +6 more
openalex   +1 more source

Multivariate Contrastive Predictive Coding with Sliding Windows for Disease Prediction from Electronic Health Records

open access: yesAdvanced Intelligent Systems, EarlyView.
Adaptive multi‐indicator contrastive predictive coding is introduced as a self‐supervised pretraining framework for multivariate EHR time series. An adaptive sliding‐window algorithm and 2D convolutional neural network encoder capture localized temporal patterns and global indicator dependencies, enabling label‐efficient disease prediction that ...
Hongxu Yuan   +3 more
wiley   +1 more source

Changes in Levels of Glucose, BUN, Creatinine, Na+, K+, Cl- and TCO

open access: green, 2011
Phattanapong Choosongsang   +3 more
openalex   +1 more source

Extramedullary Disease—Achilles Heel in Myeloma?

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Despite advances in therapy, extramedullary disease (EMD) remains an aggressive form of multiple myeloma associated with poor outcomes. Patients with true EMD, in which plasmacytomas have become completely independent of bone, have a particularly poor prognosis. The pathogenesis of EMD is driven by complex mechanisms involving loss of adhesion
Shaji Kumar   +7 more
wiley   +1 more source

Hetrombopag Added to Cyclosporine as the First‐Line Treatment for Patients With Non‐Severe Aplastic Anemia: A Phase 2 Multicenter Trial

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Non‐severe aplastic anemia (NSAA) is a heterogeneous bone marrow failure syndrome with limited standardized treatment options. Cyclosporine A (CsA) monotherapy often yields suboptimal responses, highlighting an unmet clinical need for more effective therapies.
Lele Zhang   +18 more
wiley   +1 more source

11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026. [PDF]

open access: yesDiabetes Care
American Diabetes Association Professional Practice Committee for Diabetes* .
europepmc   +1 more source

Home - About - Disclaimer - Privacy